What does CUSIP 18914F103 represent in this 13F holders report?

CUSIP 18914F103 is the security identifier for CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock used to aggregate holder disclosures.

How many institutions held CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in Q2 2021?

132 institutional investors reported CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 416,598,522
Total 13F shares: 141,911,833
Share change: -18,167,353
Total reported value: $1,889,729,052
Put/Call ratio: 52%
Price per share: $13.32
Number of holders: 132
Value change: -$201,269,843
Number of buys: 78
Number of sells: 72

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 18914F103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GREENOAKS CAPITAL PARTNERS LLC	13F	Company	23%	96,331,338	$728,265,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	6.3%	26,185,529	$197,962,000	—	31 Mar 2021	13F
BAILLIE GIFFORD & CO	13F	Company	1.2%	5,142,177	$38,875,000	—	31 Mar 2021	13F
Senator Investment Group LP	13F	Company	1.2%	5,000,000	$37,800,000	—	31 Mar 2021	13F
Alphabet Inc.	13F	Company	0.99%	4,113,742	$31,100,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	1%	4,259,579	$29,264,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.52%	2,170,505	$16,409,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.5%	2,078,899	$15,717,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	1,500,000	$10,322,000	—	31 Mar 2021	13F
LAKEWOOD CAPITAL MANAGEMENT, LP	13F	Company	0.27%	1,116,500	$8,441,000	—	31 Mar 2021	13F
Weiss Asset Management LP	13F	Company	0.24%	1,000,000	$7,560,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.23%	968,597	$7,322,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	885,193	$6,693,000	—	31 Mar 2021	13F
Casdin Capital, LLC	13F	Company	0.17%	726,511	$5,492,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.16%	657,754	$4,972,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	625,698	$4,730,000	—	31 Mar 2021	13F
Bowie Capital Management, LLC	13F	Company	0.15%	622,202	$4,704,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.12%	513,775	$3,885,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	508,295	$3,843,000	—	31 Mar 2021	13F
Comprehensive Financial Management LLC	13F	Company	0.1%	428,864	$3,242,000	—	31 Mar 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0.08%	331,291	$2,931,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	322,152	$2,435,000	—	31 Mar 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.06%	235,682	$1,782,000	—	31 Mar 2021	13F
Cerity Partners LLC	13F	Company	0.06%	229,921	$1,738,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	224,228	$1,695,000	—	31 Mar 2021	13F
LMR Partners LLP	13F	Company	0.05%	213,246	$1,612,000	—	31 Mar 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.05%	208,300	$1,575,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.05%	206,443	$1,561,000	—	31 Mar 2021	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.05%	198,587	$1,501,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	170,000	$1,285,000	—	31 Mar 2021	13F
Nathaniel S. Turner	3/4/5	Director	— class O/S missing	1,324,728	$1,258,492	—	07 Jan 2021	3/4/5
Virtu Financial LLC	13F	Company	0.04%	164,851	$1,246,000	—	31 Mar 2021	13F
Alberta Investment Management Corp	13F	Company	0.04%	150,000	$1,134,000	—	31 Mar 2021	13F
Graticule Asia Macro Advisors LLC	13F	Company	0.04%	150,000	$1,134,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	0.03%	120,000	$907,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.03%	116,353	$879,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.02%	100,000	$757,000	—	31 Mar 2021	13F
Marathon Trading Investment Management LLC	13F	Company	0.02%	90,695	$685,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.02%	86,003	$650,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	85,160	$643,000	—	31 Mar 2021	13F
Pearl River Capital, LLC	13F	Company	0.02%	81,097	$613,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	78,723	$596,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.02%	78,778	$595,000	—	31 Mar 2021	13F
FineMark National Bank & Trust	13F	Company	0.02%	75,000	$567,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	73,033	$552,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.02%	72,600	$549,000	—	31 Mar 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.02%	71,511	$541,000	—	31 Mar 2021	13F
Y-Intercept (Hong Kong) Ltd	13F	Company	0.02%	75,009	$539,000	—	31 Mar 2021	13F
Harel Insurance Investments & Financial Services Ltd.	13F	Company	0%	20,000	$505,000	—	31 Mar 2021	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.02%	66,400	$502,000	—	31 Mar 2021	13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2021

As of 30 Jun 2021, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 141,911,833 shares. The largest 10 holders included GREENOAKS CAPITAL PARTNERS LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, FMR LLC, Alphabet Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., PERCEPTIVE ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

118

Q2 2021 holders

132

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.